Nanomaterials for theranostics: recent advances and future challenges

Cited 922 time in scopus
Metadata Downloads
Nanomaterials for theranostics: recent advances and future challenges
Eun Kyung Lim; T Kim; S Paik; S Haam; Y M Huh; K Lee
Bibliographic Citation
Chemical Reviews, vol. 115, no. 1, pp. 327-394
Publication Year
Theranostics as a treatment strategy for individual patients encompasses a wide range of subjects, including personalized medicine, pharmacogenomics, and molecular imaging, in order to develop an efficient new targeted therapy and optimize drug selection via a better molecular understanding. Furthermore, theranostics aims to monitor the response to the treatment, to increase drug efficacy and safety, and to eliminate the unnecessary treatment of patients, resulting in significant cost savings for the overall healthcare system. Highly characteristic and nonrandom mutation patterns are found in well-studied oncogenes and tumor suppressor genes. Oncogenes are recurrently mutated at the same amino acid positions, leading to increased activity of the corresponding proteins.
Amer Chem Soc
Appears in Collections:
Division of Research on National Challenges > Bionanotechnology Research Center > 1. Journal Articles
Files in This Item:
  • There are no files associated with this item.

Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.